Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
The purpose of the study in Part 1 (dose escalation) and in Part 2 (dose expansion) is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) and evaluate preliminary clinical efficacy. Part 3 (dose expansion) will confirm safety and preliminary clinical activity at the RP2D. Part 4 (RP2D expansion) will assess the overall complete response (CR) in participants with intermediate-risk-non-muscle invasive bladder cancer (IR-NMIBC; means the cancer cells are only in the bladder's inner lining).
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this bladder cancer clinical trial in Orlando, FL
If you're searching for bladder cancer treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.